Cargando…

Prospective randomized comparison of effect on coronary endothelial and renal function between febuxostat and benzbromarone in hyperuricemic patients with coronary artery disease: EFEF study

BACKGROUND AND AIMS: There are two types of serum uric acid‐lowering agents, the xanthine oxidoreductase (XO) inhibitor and non‐XO inhibitor. We investigated whether febuxostat, XO inhibitor, could produce more favorable effects on coronary endothelial function (CEF) and renal function than benzbrom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nishino, Masami, Egami, Yasuyuki, Nakamura, Hitoshi, Ukita, Kohei, Kawamura, Akito, Matsuhiro, Yutaka, Yasumoto, Koji, Tsuda, Masaki, Tanaka, Akihiro, Okamoto, Naotaka, Matsunaga‐Lee, Yasuharu, Yano, Masamichi, Shutta, Ryu, Tanouchi, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939499/ https://www.ncbi.nlm.nih.gov/pubmed/35356803 http://dx.doi.org/10.1002/hsr2.563

Ejemplares similares

Atrial fibrillation type modulates the clinical predictive value of neutrophil-to-lymphocyte ratio for atrial fibrillation recurrence after catheter ablation()
por: Yano, Masamichi, et al.
Publicado: (2020)

Clinical impact of right ventricular-pulmonary artery uncoupling on predicting the clinical outcomes after catheter ablation in persistent atrial fibrillation patients
por: Yano, Masamichi, et al.
Publicado: (2022)

Early vascular healing of ultra-thin strut polymer-free sirolimus-eluting stents in acute coronary syndrome: USUI-ACS study
por: Matsuhiro, Yutaka, et al.
Publicado: (2022)

Predictors of bleeding events in acute decompensated heart failure patients with antithrombotic therapy: AURORA study
por: Kawanami, Shodai, et al.
Publicado: (2022)

Temporal Change in Renoprotective Effect of Tolvaptan on Patients with Heart Failure: AURORA Study
por: Nishino, Masami, et al.
Publicado: (2022)

Impact of ratio of P-wave duration to P-wave amplitude on recurrent arrhythmia characteristics and low-voltage risk score in paroxysmal atrial fibrillation patients underwent catheter ablation
por: Yano, Masamichi, et al.
Publicado: (2023)

Electrophysiological characteristics of non-pulmonary vein triggers excluding origins from the superior vena cava and left atrial posterior wall: Lessons from the self-reference mapping technique
por: Matsunaga-Lee, Yasuharu, et al.
Publicado: (2022)

Predictors of recurrence after pulmonary vein isolation in patients with normal left atrial diameter
por: Yano, Masamichi, et al.
Publicado: (2019)

Impact of admission hyperglycaemia on clinical outcomes in non‐diabetic heart failure with preserved ejection fraction
por: Yano, Masamichi, et al.
Publicado: (2021)

Impact of readmissions on octogenarians with heart failure with preserved ejection fraction: PURSUIT‐HFpEF registry
por: Nishino, Masami, et al.
Publicado: (2021)

High density lipoprotein cholesterol / C reactive protein ratio in heart failure with preserved ejection fraction
por: Yano, Masamichi, et al.
Publicado: (2021)

Orbital Atherectomy Through Left Main Stent Struts Complicated by Catheter Entrapment and Stent Avulsion
por: Matsuhiro, Yutaka, et al.
Publicado: (2020)

Predictors of cardiac function in acute heart failure patients with mid‐range ejection fraction: AURORA study
por: Yanagawa, Kyosuke, et al.
Publicado: (2019)

Woven Coronary Artery Anomaly: Optical Coherence Tomography Versus Intravascular Ultrasound
por: Yorifuji, Hiroki, et al.
Publicado: (2020)

Efficacy of functional substrate mapping to identify critical isthmus of atrial tachycardia
por: Egami, Yasuyuki, et al.
Publicado: (2023)

Lowering Uric Acid May Improve Prognosis in Patients With Hyperuricemia and Heart Failure With Preserved Ejection Fraction
por: Nishino, Masami, et al.
Publicado: (2022)

The C-CAT sign may predict coronary artery perforation in severe calcified lesions during coronary intervention: a case series
por: Kawamura, Akito, et al.
Publicado: (2023)

A short RP tachycardia with alternating ventriculoatrial interval, but identical atrial activation sequence: What is the mechanism?
por: Egami, Yasuyuki, et al.
Publicado: (2020)

WATCHMAN FLX implantation with an extremely small left atrial appendage ostium
por: Yano, Masamichi, et al.
Publicado: (2022)

High-density activation map of atrial tachycardia within left atrial appendage
por: Matsunaga-Lee, Yasuharu, et al.
Publicado: (2022)

Implantation of three transcatheter aortic valves for embolization of two valves caused by under-expansion: a case report
por: Tsuda, Masaki, et al.
Publicado: (2020)

A Case of Sudden Cardiac Death due to Pilsicainide-Induced Torsades de Pointes
por: Nakatani, Shimpei, et al.
Publicado: (2014)

Comparison of the Effects of Allopurinol and Febuxostat on the Values of Triglycerides in Hyperuricemic Patients
por: Ziga-Smajic, Nermina, et al.
Publicado: (2020)

Valsalva Aneurysm Filled with Thrombi Mimicking a Cardiac Tumor
por: Lee, Yasuharu, et al.
Publicado: (2012)

Dotinurad versus benzbromarone in Japanese hyperuricemic patient with or without gout: a randomized, double-blind, parallel-group, phase 3 study
por: Hosoya, Tatsuo, et al.
Publicado: (2020)

A comparative study of efficacy and safety of febuxostat and allopurinol in pyrazinamide-induced hyperuricemic tubercular patients
por: Pichholiya, Meenu, et al.
Publicado: (2016)

Febuxostat attenuates ER stress mediated kidney injury in a rat model of hyperuricemic nephropathy
por: He, Li, et al.
Publicado: (2017)

Cardiovascular Safety of Febuxostat and Allopurinol in Hyperuricemic Patients With or Without Gout: A Network Meta-Analysis
por: Zhang, Shengzhao, et al.
Publicado: (2021)

One-week Impella CP support for papillary muscle rupture as a bridge to surgery: a case report
por: Kawanami, Shodai, et al.
Publicado: (2023)

Effect of febuxostat on blood pressure in hyperuricemic patients: A protocol for a systematic review and meta-analysis
por: Yao, Jia, et al.
Publicado: (2020)

Astragaloside IV improves the pharmacokinetics of febuxostat in rats with hyperuricemic nephropathy by regulating urea metabolism in gut microbiota
por: Zhao, Zhen Xiong, et al.
Publicado: (2022)

Superiority of Low‐Dose Benzbromarone to Low‐Dose Febuxostat in a Prospective, Randomized Comparative Effectiveness Trial in Gout Patients With Renal Uric Acid Underexcretion
por: Yan, Fei, et al.
Publicado: (2022)

A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout
por: Zhang, Fengchun, et al.
Publicado: (2019)

A Randomized Controlled Trial of the Effects of Febuxostat Therapy on Adipokines and Markers of Kidney Fibrosis in Asymptomatic Hyperuricemic Patients With Diabetic Nephropathy
por: Beddhu, Srinivasan, et al.
Publicado: (2016)

A non-inferiority study of the novel selective urate reabsorption inhibitor dotinurad versus febuxostat in hyperuricemic patients with or without gout
por: Hosoya, Tatsuo, et al.
Publicado: (2020)

Comment on “A Randomized, Double-Blind, Non-inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects with or Without Gout”
por: van Leeuwen, Kevin D. B., et al.
Publicado: (2019)

‘Touchdown’ technique during self-expandable transcatheter aortic valve replacement in patient with severe left ventricular outflow tract calcification: a case report
por: Tsuda, Masaki, et al.
Publicado: (2023)

Simple bailout technique using a snare catheter for wire withdrawal during balloon-expandable transcatheter aortic valve implantation: a case report
por: Tsuda, Masaki, et al.
Publicado: (2023)

Benzbromarone, Quercetin, and Folic Acid Inhibit Amylin Aggregation
por: López, Laura C., et al.
Publicado: (2016)

Reduced Incidence of Stroke in Patients with Gout Using Benzbromarone
por: Niu, Sheng-Wen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bf1shhflvod4invtqm8klceli7